- Rituximab in Membranous Nephropathy2021 | First Faculty of Medicine
- Secondary membranous nephropathy - one center experience2005 | First Faculty of Medicine, Central Library of Charles University
- The management of membranous nephropathy-an update2022 | First Faculty of Medicine
- Treatment of lupus membranous nephropathy with cyclosporin. Commentary on: JASN 20,2009,901-9112009 | First Faculty of Medicine
- Identification of target antigen in idiopatic membranous nephropathy. Commentary on: NEJM 361,2009,s. 11-212009 | First Faculty of Medicine
- Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy2021 | First Faculty of Medicine
- Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy2013 | First Faculty of Medicine
- Secondary causes of membranous nephropathy2004 | First Faculty of Medicine
- Secondary causes of membranous nephropathyPublication without faculty affiliation
- HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients2021 | First Faculty of Medicine
- Our experience in the treatment of membranous nephropathy with cyclosporine2005 | First Faculty of Medicine
- Is imunnospresive treatment of idiopathic membranous nephropathy effective?2004 | First Faculty of Medicine
- Treatment of idiopathic membranous nephropathy with chlorambucil and cyclosporineí2000 | First Faculty of Medicine
- Long-Term Outcome of Patients with Membranous Nephropathy-One-Centre ExperiencePublication without faculty affiliation
- A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study2015 | First Faculty of Medicine
- Membranous nephropathy in young diabetic man with mercury intoxication-case report.Publication without faculty affiliation
- The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis2020 | First Faculty of Medicine
- Long-term outcome of patients with idiopathic membranous nephropathy2006 | First Faculty of Medicine
- What patients with idiopatic membranous nephropathy may be succesfully treated with rituximab? Commentary2006 | First Faculty of Medicine
- Urinary Excretion of 8-isoprostan and the IL-6/EGF ratio in the urine with primary and secondary glomerulopathies (ANCA-positive renal vasculitis, lupus nephritis IgA nephropathy and membranous nephropathyPublication without faculty affiliation
- Urinary 8-isoprostane and IL-6/EGF ratio in ANCA - positive renal vasculitis. Lupus nephritis and IgA and membranous nephropathyPublication without faculty affiliation
- Urinary 8-isoprostane and IL-6/EGF ratio in ANCA - positive renal vasculitis. Lupus nephritis and IgA and membranous nephropathy2001 | Faculty of Physical Education and Sport
- New knowledge about membranous nephropathy.Commentary on:NEJM 364,2011,616-6262011 | First Faculty of Medicine
- Renal involvement in primary antiphospholipid syndrome:retrospective analysis of 0160patients.Commentary on:Clin JASN65,2010,1211-172010 | First Faculty of Medicine
- Urinary 8-isoprostane and IL-6/EGF in primary and secondary glomerulonefritides (ANCA-positive renal vasculitis, lupus nephritis IgA nephropathy and membranous nephropathy).2000 | First Faculty of Medicine
- Familial hematuria: A review2017 | Second Faculty of Medicine
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases2021 | First Faculty of Medicine
- Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives2022 | First Faculty of Medicine
- Secondary causes of membranous glomerulonephritis (2)Publication without faculty affiliation
- Long-Term Outcome of Patients with ANCA-Associated Renal Vasculitis - One-Centre ExperiencePublication without faculty affiliation